These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 2178026

  • 1. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
    Yoburn BC, Sierra V, Lutfy K.
    Brain Res; 1990 Oct 08; 529(1-2):143-8. PubMed ID: 2178026
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat.
    Bhargava HN, Matwyshyn GA, Reddy PL, Veeranna.
    Gen Pharmacol; 1993 Nov 08; 24(6):1351-7. PubMed ID: 8112506
    [Abstract] [Full Text] [Related]

  • 8. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL, Veeranna, Matwyshyn GA, Thorat SN, Bhargava HN.
    Gen Pharmacol; 1994 Mar 08; 25(2):355-61. PubMed ID: 8026736
    [Abstract] [Full Text] [Related]

  • 9. The role of opioid receptor density in morphine tolerance.
    Lutfy K, Yoburn BC.
    J Pharmacol Exp Ther; 1991 Feb 08; 256(2):575-80. PubMed ID: 1847202
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P, Garzón J.
    Eur J Pharmacol; 1989 Jan 02; 159(1):9-23. PubMed ID: 2565240
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors.
    Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW.
    Neuropharmacology; 1990 Sep 02; 29(9):805-10. PubMed ID: 1963479
    [Abstract] [Full Text] [Related]

  • 12. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
    Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, Holaday JW.
    Eur J Pharmacol; 1989 Jan 24; 160(1):71-82. PubMed ID: 2540993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms.
    Danks JA, Tortella FC, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW, Rothman RB.
    Neuropharmacology; 1988 Sep 24; 27(9):965-74. PubMed ID: 2847072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and DADLE.
    Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE.
    Life Sci; 1988 Sep 24; 43(16):1319-24. PubMed ID: 2845219
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep 24; 238(3):990-6. PubMed ID: 3018230
    [Abstract] [Full Text] [Related]

  • 19. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC, Goodman RR, Cohen AH, Pasternak GW, Inturrisi CE.
    Life Sci; 1985 Jun 17; 36(24):2325-32. PubMed ID: 2989632
    [Abstract] [Full Text] [Related]

  • 20. Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors.
    Zagon IS, McLaughlin PJ.
    Brain Res; 1989 Feb 20; 480(1-2):16-28. PubMed ID: 2540873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.